|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310,500 KRW | +0.16% |
|
+0.65% | -11.91% |
On January 31, 2024, Aptose Biosciences Inc. closed the transaction. The company issued 2,105,263 common shares at an issue price of $1.90 per share for the gross proceeds of $3,999,999.7 yielding ownership of 19.03% of the outstanding Common Shares. The Company also issued investor warrants to purchase Common Shares at an exercise price of $1.71 per Warrant Share.
The Private Placement have been subject to the approval of the Toronto Stock Exchange (?TSX?) and Nasdaq.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 310,500 KRW | +0.16% | +0.65% | 2.86B | ||
| 1.7 CAD | +4.94% | +0.59% | 19.52M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -11.91% | 2.86B | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
HANMI PHARM. CO., LTD. 
